Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > SeaGen ADC product revenues and valuations

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Nov 02, 2022 12:54am

108 Views

Post# 35065265

RE:RE:RE:SeaGen ADC product revenues and valuations

The Immunomedics (Trodelvy) story is worth a read. Certainly didn't smell of roses for a long time, whiff of something else.

Biobob wrote: Interesting... did any of those company trade like a worthless POS before they reached their glory days... was there any anticipation of success from analysts, from trial participants and their relatives.. some word of mouth, from speculators. Are we seing any of this atm, any hopefull signs of success to come...

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta